| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |